Perrigo (PRGO) EBIT Growth (1y) (2013 - 2026)
Perrigo (PRGO) EBIT Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | -150.77% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -10.00% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -0.93% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | -9.25% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -97.30% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 4.05% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 12.73% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Perrigo | 1.94 Bn | 1.54 Bn | 313.90 Mn | -48.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -48.24% |
| Mar 28, 2026 | -893.82% |
| Dec 31, 2025 | -1,227.06% |
| Sep 27, 2025 | -9.70% |
| Jun 28, 2025 | 271.32% |
| Mar 29, 2025 | 184.96% |
| Dec 31, 2024 | 832.05% |
| Sep 28, 2024 | 29.47% |
| Jun 29, 2024 | -146.65% |
| Mar 30, 2024 | -213.81% |
| Dec 31, 2023 | -150.32% |
| Sep 30, 2023 | 87.61% |
| Jul 1, 2023 | 923.19% |
| Apr 1, 2023 | 123.50% |
| Dec 31, 2022 | -33.62% |
| Oct 1, 2022 | -92.45% |
| Jul 2, 2022 | 94.52% |
| Apr 2, 2022 | -57.78% |
| Dec 31, 2021 | 24.20% |
| Oct 2, 2021 | 458.34% |